OneMedNet Corporation (ONMD) 10-Year Financial Performance & Capital Metrics

ONMD • • Industrial / General

HealthcareHealthcare ITMedical Imaging & DiagnosticsGeneral Medical Imaging Software

AboutOneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.Show more

Revenue $643K -37.0%
EBITDA -$10M -39.9%
Net Income -$10M +70.0%
EPS (Diluted) -0.36 +92.5%
Gross Margin -43.7% -245.9%
EBITDA Margin -1484.91% -122.1%
Operating Margin -1493.78% -122.6%
Net Margin -1575.27% +52.4%
ROE -
ROIC -
Debt/Equity -
Interest Coverage -65.34 +89.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 90 (top 10%)

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-16.18%

TTM-48.32%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM92.17%

EPS CAGR

10Y-

5Y-

3Y-

TTM94.52%

ROCE

10Y Avg-

5Y Avg-

3Y Avg-

Latest-

Peer Comparison

General Medical Imaging Software

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GEHCGE HealthCare Technologies Inc.	37.59B	82.51	19.01	0.61%	10.95%	21.68%	4.12%	1.08
ACONAclarion, Inc.	4.22M	4.00	-0.00	-39.36%	-108.68%	-58.67%
ONMDOneMedNet Corporation	43.35M	0.85	-2.36	-37.02%	-411.11%

Profit & Loss

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	824.03K	1.09M	1.15M	1.02M	643K
Revenue Growth %	-	0.32%	0.06%	-0.11%	-0.37%
Cost of Goods Sold+	611.66K	1.21M	1.51M	1.15M	924K
COGS % of Revenue	0.74%	1.1%	1.31%	1.13%	1.44%
Gross Profit+	212.37K	-113.41K	-360K	-129K	-281K
Gross Margin %	0.26%	-0.1%	-0.31%	-0.13%	-0.44%
Gross Profit Growth %	-	-1.53%	-2.17%	0.64%	-1.18%
Operating Expenses+	3.14M	2.6M	7.36M	6.72M	9.32M
OpEx % of Revenue	3.82%	2.38%	6.38%	6.59%	14.5%
Selling, General & Admin	2.38M	1.8M	13.84M	4.66M	7.86M
SG&A % of Revenue	2.89%	1.65%	12%	4.56%	12.22%
Research & Development	307.27K	642.76K	1.59M	2.06M	1.47M
R&D % of Revenue	0.37%	0.59%	1.38%	2.02%	2.28%
Other Operating Expenses	454.61K	152.46K	-8.07M	0	0
Operating Income+	-2.93M	-2.71M	-7.71M	-6.85M	-9.61M
Operating Margin %	-3.56%	-2.48%	-6.69%	-6.71%	-14.94%
Operating Income Growth %	-	0.08%	-1.85%	0.11%	-0.4%
EBITDA+	-2.92M	-2.7M	-7.69M	-6.83M	-9.55M
EBITDA Margin %	-3.54%	-2.47%	-6.67%	-6.68%	-14.85%
EBITDA Growth %	-	0.08%	-1.85%	0.11%	-0.4%
D&A (Non-Cash Add-back)	13.92K	14.47K	25K	28K	57K
EBIT	-2.93M	-2.75M	-30.43M	-33.75M	-9.98M
Net Interest Income+	193.55K	-195.38K	-403.31K	-11K	-147K
Interest Income	193.55K	0	0	0	0
Interest Expense	0	195.38K	403.31K	11K	147K
Other Income/Expense	110.55K	-230.29K	-22.72M	-26.91M	-522K
Pretax Income+	-2.82M	-2.94M	-30.43M	-33.76M	-10.13M
Pretax Margin %	-3.42%	-2.69%	-26.4%	-33.07%	-15.75%
Income Tax+	0	0	17K	18K	2K
Effective Tax Rate %	1%	1%	1%	1%	1%
Net Income+	-2.82M	-2.94M	-30.45M	-33.78M	-10.13M
Net Margin %	-3.42%	-2.69%	-26.41%	-33.09%	-15.75%
Net Income Growth %	-	-0.04%	-9.35%	-0.11%	0.7%
Net Income (Continuing)	-2.82M	-2.94M	-30.45M	-33.78M	-10.13M
Discontinued Operations	0	0	0	0	0
Minority Interest	0	0	0	0	0
EPS (Diluted)+	-0.19	-0.20	-2.51	-4.77	-0.36
EPS Growth %	-	-0.05%	-11.55%	-0.9%	0.92%
EPS (Basic)	-0.19	-0.20	-2.51	-4.77	-0.36
Diluted Shares Outstanding	14.96M	14.96M	12.13M	7.08M	28.08M
Basic Shares Outstanding	14.96M	14.96M	12.13M	7.08M	28.08M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	293.62K	833.29K	391K	364.19K	3.62M
Cash & Short-Term Investments	79.18K	699.32K	271K	47.01K	3.02M
Cash Only	79.18K	699.32K	271K	47.01K	172K
Short-Term Investments	0	0	0	0	2.85M
Accounts Receivable	195.37K	91.74K	19K	151.64K	213K
Days Sales Outstanding	86.54	30.67	6.01	54.21	120.91
Inventory	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-
Other Current Assets	19.07K	42.23K	101K	165.54K	385K
Total Non-Current Assets+	34.3K	49.77K	898K	98.87K	108K
Property, Plant & Equipment	34.3K	49.77K	83K	98.87K	108K
Fixed Asset Turnover	24.03x	21.94x	13.89x	10.33x	5.95x
Goodwill	0	0	0	0	0
Intangible Assets	0	0	0	0	0
Long-Term Investments	0	0	0	0	0
Other Non-Current Assets	0	0	815K	0	0
Total Assets+	327.91K	883.06K	1.29M	463.06K	3.73M
Asset Turnover	2.51x	1.24x	0.89x	2.20x	0.17x
Asset Growth %	-	1.69%	0.46%	-0.64%	7.05%
Total Current Liabilities+	1.55M	4.75M	26.1M	12.83M	19.23M
Accounts Payable	0	0	1.18M	4.18M	6.37M
Days Payables Outstanding	-	-	283.94	1.33K	2.52K
Short-Term Debt	1.05M	3.35M	24.74M	4.64M	8.76M
Deferred Revenue (Current)	106.37K	642.35K	184K	254K	561K
Other Current Liabilities	391.12K	758.82K	0	0	283K
Current Ratio	0.19x	0.18x	0.01x	0.03x	0.19x
Quick Ratio	0.19x	0.18x	0.01x	0.03x	0.19x
Cash Conversion Cycle	-	-	-	-	-
Total Non-Current Liabilities+	1.64M	1.83M	1.54M	489.61K	449K
Long-Term Debt	1.55M	1.55M	1.5M	465.02K	0
Capital Lease Obligations	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0
Other Non-Current Liabilities	93.19K	287.61K	44K	24.58K	449K
Total Liabilities	3.19M	6.59M	27.65M	13.32M	19.68M
Total Debt+	2.6M	4.9M	26.24M	5.1M	8.76M
Net Debt	2.52M	4.2M	25.97M	5.05M	8.59M
Debt / Equity	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-
Interest Coverage	-	-13.87x	-19.13x	-623.00x	-65.34x
Total Equity+	-2.86M	-5.7M	-26.36M	-12.86M	-15.95M
Equity Growth %	-	-0.99%	-3.62%	0.51%	-0.24%
Book Value per Share	-0.19	-0.38	-2.17	-1.82	-0.57
Total Shareholders' Equity	-2.86M	-5.7M	-26.36M	-12.86M	-15.95M
Common Stock	383	434	0	2.36K	2K
Retained Earnings	-22.37M	-25.31M	-57.66M	-55.08M	-101.57M
Treasury Stock	0	0	0	0	-529K
Accumulated OCI	0	0	0	0	0
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-2.13M	-1.84M	-4.7M	-4.79M	-6.98M
Operating CF Margin %	-2.58%	-1.69%	-4.08%	-4.69%	-10.86%
Operating CF Growth %	-	0.13%	-1.55%	-0.02%	-0.46%
Net Income	-2.82M	-2.94M	-30.45M	-33.78M	-10.13M
Depreciation & Amortization	13.92K	14.47K	25K	28K	57K
Stock-Based Compensation	606.51K	97.87K	1.86M	1.48M	628K
Deferred Taxes	0	0	0	0	0
Other Non-Cash Items	-234.5K	0	23.89M	26.88M	956K
Working Capital Changes	310.59K	984.13K	-29K	611K	1.5M
Change in Receivables	-91.89K	81.09K	73K	-133K	-61K
Change in Inventory	0	0	0	0	0
Change in Payables	0	0	1.93M	717K	1.49M
Cash from Investing+	0	-29.94K	-58K	-44K	-1.98M
Capital Expenditures	0	-29.94K	-58K	-44K	-51K
CapEx % of Revenue	-	0.03%	0.05%	0.04%	0.08%
Acquisitions	-	-	-	-	-
Investments	-	-	-	-	-
Other Investing	0	0	0	0	0
Cash from Financing+	1.33M	2.49M	4.33M	4.61M	9.09M
Debt Issued (Net)	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-
Dividends Paid	0	0	0	0	0
Share Repurchases	-	-	-	-	-
Other Financing	0	0	84.92M	-1.53M	-100K
Net Change in Cash	-	-	-	-	-
Free Cash Flow+	-2.13M	-1.87M	-4.76M	-4.83M	-7.03M
FCF Margin %	-2.58%	-1.72%	-4.13%	-4.74%	-10.94%
FCF Growth %	-	0.12%	-1.54%	-0.02%	-0.45%
FCF per Share	-0.14	-0.13	-0.39	-0.68	-0.25
FCF Conversion (FCF/Net Income)	0.75x	0.63x	0.15x	0.14x	0.69x
Interest Paid	0	0	0	0	26K
Taxes Paid	0	0	0	0	18K

Key Ratios

Metric	2020	2021	2022	2023	2024
Gross Margin	25.77%	-10.39%	-31.22%	-12.63%	-43.7%
Net Margin	-342.41%	-269.37%	-2641.02%	-3308.52%	-1575.27%
Interest Coverage	-	-13.87x	-19.13x	-623.00x	-65.34x
FCF Conversion	0.75x	0.63x	0.15x	0.14x	0.69x
Revenue Growth	-	32.49%	5.61%	-11.45%	-37.02%

Revenue by Segment

	2024
Subscription Revenue	351K
Subscription Revenue Growth	-

Frequently Asked Questions

Growth & Financials

OneMedNet Corporation (ONMD) reported $0.5M in revenue for fiscal year 2024. This represents a 40% decrease from $0.8M in 2020.

OneMedNet Corporation (ONMD) saw revenue decline by 37.0% over the past year.

OneMedNet Corporation (ONMD) reported a net loss of $2.0M for fiscal year 2024.

Dividend & Returns

OneMedNet Corporation (ONMD) had negative free cash flow of $7.9M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener